Prevalence of use study for amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) in military entrance processing stations (MEPS) specimens

Journal of Analytical Toxicology

Volumn 30, Issue 5, 2006, Pages 319-322

  Klette, Kevin L ^a   Kettle, Aaron R ^a   Jamerson, Matthew H ^a  

^a Navy Drug Screening Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYETHYLAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; METHAMPHETAMINE; PERIODATE SODIUM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG ABUSE; DRUG SCREENING; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PREVALENCE; SOLDIER; SOLID PHASE EXTRACTION; UNITED STATES; URINALYSIS;

EID: 33747699107     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/30.5.319     Document Type: Article

References (7)

1. M.J. Ellenhorn and D.G. Barceloux. Medical Toxicology Diagnosis and Treatment of Human Poisoning. Elsevier Science, Amsterdam, Netherlands, 1988, p 626.
2. Office of the Department of Defense Coordinator for Drug Enforcement Policy and Support Memorandum. Drug Urinalysis Testing Levels, 1997.
3. M.A. ElSohly, D.F. Stanford, D. Sherman, H. Shah, D. Bernot, and C.E. Turner. A procedure for eliminating interferences from ephedra and related compounds in the GC/MS analysis of amphetamine and methamphetamine. J. Anal. Toxicol. 16: 109-111 (1992).
4. K.L. Klette, M.H. Jamerson, C.L. Morris-Kukoski, A.R. Kettle, and J.J. Snyder. Rapid simultaneous determination of amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) in urine by fast gas chromatography-mass spectrometry. J. Anal. Toxicol. 29: 669-674 (2005).
5. Office of National Drug Control Policy. National Synthetic Drug Action Plan. http://www.whitehousedrugpolicy.gov/publications/ national_synth_drugs/ factsheet.html (accessed 2005).
6. Federal Register, Vol. 69, No. 71, 2004.
7. S.E. McCabe, J.R. Knight, C.J. Teter, and H. Weshsler. Non-medical use of prescription stimulants among U.S. college students: prevalence and correlates from a national survey. Addiction 100: 96 (2005)